TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer
Sign Up to like & getrecommendations! Published in 2019 at "Oncology Reports"
DOI: 10.3892/or.2019.7258
Abstract: Cisplatin is a common chemotherapeutic agent against ovarian cancer; however, drug resistance is a major limiting factor for its use in clinical treatment. The underlying mechanisms of cisplatin resistance in ovarian cancer have not yet… read more here.
Keywords: cancer; ovarian cancer; trp14; resistance cisplatin ... See more keywords